SLU-PP-332 is a synthetic small molecule that activates the estrogen-related receptors (ERRs), a family of nuclear receptors that help control how cells produce and use energy. Because rodent studies have linked it to changes in muscle metabolism that resemble the effects of endurance training, it is often described in the scientific literature as an exercise mimetic. This guide covers what SLU-PP-332 is, the mechanism researchers have studied, the main areas of research and how to handle it in the lab.
What is SLU-PP-332?
SLU-PP-332 is a non-peptide synthetic compound designed as an agonist of the estrogen-related receptors ERR alpha, ERR beta and ERR gamma. It is usually described as a pan-ERR agonist, with its strongest reported activity at ERR alpha. The SLU prefix reflects its origin in an academic medicinal chemistry program at Saint Louis University.
Despite their name, the estrogen-related receptors do not bind estrogen. They are orphan nuclear receptors: transcription factors with no confirmed natural hormone ligand that are active on their own and regulate genes involved in mitochondrial function, oxidative metabolism and fatty acid use. Small molecules that push these receptors to higher activity have been difficult to find, which is one reason SLU-PP-332 has drawn attention as a research tool.
Unlike most compounds in the PRIME catalog, SLU-PP-332 is not a peptide. That matters at the bench, because its solubility and handling differ from those of lyophilized peptides, as covered in the handling section below. SLU-PP-332 is a research compound. It is not an approved medicine in the US and has no approved use in people.
How SLU-PP-332 works: mechanism studied in research
The estrogen-related receptors sit at the center of a gene network that governs cellular energy production. ERR alpha in particular works with the coactivator PGC-1 alpha, a well-known regulator of mitochondrial biogenesis, to switch on genes for the citric acid cycle, oxidative phosphorylation and fatty acid oxidation. In skeletal muscle, heart and brown fat, this network helps set how much oxidative capacity a tissue has.
In published preclinical work, SLU-PP-332 has been reported to:
- Increase ERR transcriptional activity in cell-based reporter assays
- Raise expression of genes tied to mitochondrial function and oxidative metabolism in muscle cells
- Shift rodent skeletal muscle toward a more oxidative fiber profile, similar to changes seen with endurance training
- Increase whole-body energy expenditure and fatty acid use in rodent models
These observations are the basis of the exercise mimetic label. The term describes a pattern seen in animal and cell studies. It is not evidence that the compound reproduces the effects of exercise in people. Open questions remain about how selective SLU-PP-332 is across the three ERR isoforms, which of its effects depend on which receptor, and how its actions compare with those of other metabolic signaling tools such as AMPK activators.
Areas of research
SLU-PP-332 has been studied mainly in cell culture and rodent models. Research areas include:
- Skeletal muscle metabolism: oxidative fiber type, mitochondrial content and running endurance in mice
- Obesity and metabolic models: body weight, fat mass, glucose handling and insulin sensitivity in diet-induced and genetic rodent models
- Mitochondrial biogenesis: the ERR and PGC-1 alpha axis as a route to building oxidative capacity
- Cardiac energetics: ERR signaling in heart muscle and in rodent models of heart failure
- Aging research: ERR activity and mitochondrial function in aged rodent tissues, including kidney
The evidence base is preclinical. Researchers use SLU-PP-332 to probe ERR biology in controlled systems, often alongside other mitochondrial and metabolic compounds.
SLU-PP-332 key facts table
| Property | Detail |
|---|---|
| Compound class | Synthetic small molecule, nuclear receptor agonist |
| Target | Estrogen-related receptors (ERR alpha, beta, gamma), strongest reported at ERR alpha |
| Type | Non-peptide organic compound |
| Form supplied | Solid research material; see the product label for format |
| Research status | Preclinical research compound; not an approved medicine in the US |
| Common research models | Cell-based assays, rodent metabolic and muscle models |
| Storage | Cool, dry and protected from light; follow the label |
Handling and storage in the lab
Because SLU-PP-332 is a small molecule rather than a peptide, standard peptide reconstitution routines do not automatically apply. General lab handling points:
- Check the format first. Read the label and product documentation before preparing any solution, since solid small molecules can be supplied in more than one format.
- Solvent choice. Many hydrophobic small molecules have limited water solubility, and in cell work they are often prepared as stock solutions in an organic solvent such as DMSO. Bacteriostatic water is the usual choice for lyophilized peptides but may not be suitable here. Choose a solvent that fits your assay and include matching vehicle controls.
- Storage of solid material. Keep it sealed, dry and away from light and heat. A refrigerator or freezer is appropriate for longer storage.
- Storage of solutions. Aliquot stock solutions to avoid repeated freeze-thaw cycles, label each vial with the compound, solvent and preparation date, and store cold.
- General practice. Wear gloves and eye protection, work on a clean surface and record lot numbers for traceability.
Quality and lab results
For a small molecule used in mechanistic studies, identity and purity are central to interpreting results. An impurity or degradation product with its own biological activity can easily confound a receptor-focused experiment. Every PRIME batch is tested, and the certificate of analysis (COA) for each lot is published so researchers can confirm what they are working with before an experiment begins. You can review current reports on the PRIME lab results page. Match the lot number on your vial to its COA and keep a copy with your lab records.
To order research material, see SLU-PP-332 research compound.
Related research
SLU-PP-332 is often discussed alongside other compounds studied in mitochondrial and metabolic research:
- MOTS-c research guide: a mitochondria-derived peptide studied in metabolic and exercise-related models
- 5-Amino-1MQ research guide: a small-molecule NNMT inhibitor investigated in fat-cell metabolism research
- MOTS-c vs SS-31: a comparison of two mitochondria-focused research peptides
SLU-PP-332 FAQ
What is SLU-PP-332 used for in research?
SLU-PP-332 is used as a tool compound to activate the estrogen-related receptors in cell and rodent models. Researchers use it to study mitochondrial biogenesis, oxidative metabolism in skeletal muscle, energy expenditure and ERR signaling in tissues such as heart and kidney.
Why is SLU-PP-332 called an exercise mimetic?
In rodent studies it has been associated with gene expression and muscle fiber changes that resemble those seen after endurance training, along with higher energy expenditure. The label describes these preclinical observations. It does not mean the compound has been shown to replicate exercise in people.
Is SLU-PP-332 a peptide or a SARM?
Neither. SLU-PP-332 is a synthetic small molecule that targets the estrogen-related receptors. It is not a peptide, and it does not act on androgen receptors the way SARMs are designed to.
Has SLU-PP-332 been tested in humans?
The published research on SLU-PP-332 is preclinical, from cell culture and animal models. It is not an approved medicine, and PRIME supplies it strictly for laboratory research, not for human consumption.
How should SLU-PP-332 be stored?
Keep the solid material sealed, dry, cold and protected from light. Prepared stock solutions should be aliquoted, labeled and stored cold to limit freeze-thaw cycles. Follow the product label for specific guidance.
For laboratory research use only. Not for human consumption. Not a drug, food or cosmetic.